ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.

Rebecca L Shattuck-Brandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.